JP Patent

JP4376957B2 — 電子部品用接着剤

Assigned to Sekisui Chemical Co Ltd · Expires 2009-12-02 · 16y expired

What this patent protects

Patent listed against Otezla.

Drugs covered by this patent

Otezla (APREMILAST) · Amgen

Patent Metadata

Patent number: JP4376957B2
Jurisdiction: JP
Classification: —
Expires: 2009-12-02
Drug substance claim: No
Drug product claim: No
Assignee: Sekisui Chemical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.